Literature DB >> 19752083

Increased prevalence of renal and urinary tract anomalies in children with Down syndrome.

Juan C Kupferman1, Charlotte M Druschel, Gabriel S Kupchik.   

Abstract

OBJECTIVE: The goal was to investigate the prevalence of renal and urinary tract anomalies (RUTAs) in a Down syndrome (DS) population.
METHODS: Data were obtained from the New York State Congenital Malformation Registry (NYS-CMR) in this retrospective cohort study. The occurrence of RUTAs was assessed for children with and without DS who were born in NYS between 1992 and 2004. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated for each malformation.
RESULTS: Between 1992 and 2004, 3832 children with DS and 3 411 833 without DS were born in NYS. The prevalence of RUTAs in the DS population was 3.2%, compared with 0.7% in the NYS population (OR: 4.5 [95% CI: 3.8 -5.4]). Children with DS had significantly increased risks of anterior urethral obstruction (OR: 29.7 [95% CI: 4.0 -217.7]), cystic dysplastic kidney (OR: 4.5 [95% CI: 1.5-14.1]), hydronephrosis (OR: 8.7 [95% CI: 6.8 -11.0]), hydroureter (OR: 8.5 [95% CI: 3.5-20.4]), hypospadias (OR: 2.0 [95% CI: 1.4 -2.9]), posterior urethral valves (OR: 7.1 [95% CI: 1.8 -28.8]), prune belly syndrome (OR: 11.9 [95% CI: 1.6 - 85.4]), and renal agenesis (OR: 5.4 [95% CI: 2.8 -10.4]). There was no significantly increased risk of ectopic kidney (OR: 1.6 [95% CI: 0.2-11.2]) or ureteropelvic junction obstruction (OR: 1.4 [95% CI: 0.2-9.9]) in the DS population.
CONCLUSION: Children with DS have significantly increased risks of RUTAs.

Entities:  

Mesh:

Year:  2009        PMID: 19752083     DOI: 10.1542/peds.2009-0181

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  17 in total

1.  Evaluation of structural anomalies of kidney and urinary tract in children with Down syndrome.

Authors:  Mayank Jain; Ankur Singh; Mukta Mantan; Seema Kapoor
Journal:  Indian J Pediatr       Date:  2013-09-21       Impact factor: 1.967

2.  Mutation screening of BMP4 and Id2 genes in Chinese patients with congenital ureteropelvic junction obstruction.

Authors:  Jun Li He; Jun Hong Liu; Feng Liu; Ping Tan; Tao Lin; Xu Liang Li
Journal:  Eur J Pediatr       Date:  2011-09-17       Impact factor: 3.183

Review 3.  Effects of posterior urethral valves on long-term bladder and sexual function.

Authors:  Seppo Taskinen; Jukka Heikkilä; Risto Rintala
Journal:  Nat Rev Urol       Date:  2012-11-13       Impact factor: 14.432

Review 4.  Genetics of human congenital urinary bladder disease.

Authors:  Adrian S Woolf; Helen M Stuart; William G Newman
Journal:  Pediatr Nephrol       Date:  2013-04-13       Impact factor: 3.714

5.  Commonality in Down and fetal alcohol syndromes.

Authors:  Jeffrey P Solzak; Yun Liang; Feng C Zhou; Randall J Roper
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2013-04-03

Review 6.  Imaging findings in Down syndrome.

Authors:  Rupa Radhakrishnan; Alexander J Towbin
Journal:  Pediatr Radiol       Date:  2014-04-16

7.  Impact of acute kidney injury in patients prescribed angiotensin-converting enzyme inhibitors over the first two years of life.

Authors:  Daishi Hirano; Saori Miwa; Daisuke Kakegawa; Chisato Umeda; Yoichi Takemasa; Ai Tokunaga; Kawakami Yuhei; Akira Ito
Journal:  Pediatr Nephrol       Date:  2021-01-19       Impact factor: 3.714

8.  Developmental abnormalities, blood pressure variability and renal disease in Riley Day syndrome.

Authors:  L Norcliffe-Kaufmann; F B Axelrod; H Kaufmann
Journal:  J Hum Hypertens       Date:  2011-12-01       Impact factor: 3.012

Review 9.  Clinical practice. The care of children with Down syndrome.

Authors:  Michel E Weijerman; J Peter de Winter
Journal:  Eur J Pediatr       Date:  2010-07-15       Impact factor: 3.183

10.  Novel insights from fetal and placental phenotyping in 3 mouse models of Down syndrome.

Authors:  April D Adams; Victoria Hoffmann; Laura Koehly; Faycal Guedj; Diana W Bianchi
Journal:  Am J Obstet Gynecol       Date:  2021-03-22       Impact factor: 10.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.